Carina Ruwolt

Carina Ruwolt is a highly accomplished professional with a strong background in the medical and pharmaceutical industries.

Carina Ruwolt pursued her Doctor of Medicine (MD) degree from Charité University Medicine Berlin and also studied Medicine at Université Claude Bernard Lyon 1, showcasing her commitment to medical education and expertise.

With an impressive professional journey, Carina Ruwolt currently serves as the Director of Strategy Pharmaceuticals at Bayer Pharmaceuticals, a role that requires strategic planning and industry knowledge.

Prior to her current position, Carina had valuable experiences at renowned organizations including Boston Consulting Group (BCG) as a Project Leader and Consultant, where she honed her consulting skills.

Carina Ruwolt also has a background in neurosurgery, having worked at the University of Miami, Miller School of Medicine, Mount Sinai Health System, and as a Visiting Associate at The Boston Consulting Group.

Her expertise extends to cardiac surgery, as she had a notable role at Stanford University School of Medicine, demonstrating her versatility and depth in the medical field.

Carina Ruwolt's diverse professional journey and rich experiences make her a prominent figure in the medical and pharmaceutical sectors, showcasing her strategic acumen, consulting skills, and surgical expertise.